Press Releases

Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines

London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest $1 billion by 2030 to further expand its US manufacturing and R&D...

API China 2025 Concludes with Strong Turnout and Industry-Wide Momentum

Asia’s leading pharma show draws 200,000 visits and nearly 4,000 exhibitors across three co-located events in Guangzhou Beijing, The 92nd edition of API China successfully wrapped up on 23 May, reaffirming its role as a cornerstone event for the pharmaceutical, health, and nutrition...

Evertis Selects Honeywell Aclar® Technology to Enhance Pharmaceutical Packaging

On June 6, 2025 – Honeywell announced that Evertis, a leading producer of film for packaging, has selected Aclar® film to be used by its Evercare pharmaceutical brand. Evertis’ selection of Aclar films will help ensure that patients around...

FedEx Strengthens Healthcare Capabilities in Asia Pacific with CEIV Pharma Certification

First global integrator to achieve CEIV Pharma certification for ground handling across air hubs and ramps Federal Express Corporation, one of the world’s largest express transportation companies, announced today that its hubs at Guangzhou Baiyun International Airport, China (CAN)...

CPHI & PMEC China Sees Surge in International Attendance as Global Pharma Trade Outlook Strengthens

CPHI & PMEC China (June 24-26th) returns to the Shanghai New International Expo Center amid a marked surge in international interest, with industry momentum rebounding following a string of positive developments in global trade and pharmaceutical investment. The 2025 edition...

Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming New Drug R&D Logic, Enabling One-Stop Innovative Drug Discovery

Artificial intelligence has rapidly evolved from academic theory into a transformative force in pharmaceutical R&D. From early QSAR models to neural networks, and now to AlphaFold3, AI has progressively unlocked deeper biological insights. By integrating structure prediction, molecular modeling,...

Syntegon Reports Accelerated Growth in 2024 Results

Syntegon delivers record results in 2024 New strategy fuels accelerated growth following CEO transition in late 2023 Order intake increased by 11% to 1.8 billion EUR and revenue grew by 7% to 6 billion EUR Strong EBITDA improvement by 15%...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read